Exosomal miR-218-5p/miR-363-3p from Endothelial Progenitor Cells Ameliorate Myocardial Infarction by Targeting the p53/JMY Signaling Pathway

<div>Immunofluorescence staining to detect the relative expression levels of <i>α</i>-SMA (a), vimentin (b), CD31 (c), and VEGFR-2 (d) in CFs treated with miR-218-5p and miR-363-3p mimics and inhibitors. The photographs were taken with a laser confocal microscope (Zeiss, LSM700), magnification: 120x.</div>

Oxidative Medicine and Cellular Longevity

fig4

Figure 4

Figure 4: Exosomal miR-218-5p/miR-363-3p from Endothelial Progenitor Cells Ameliorate Myocardial Infarction by Targeting the p53/JMY Signaling Pathway 

Figure 4 | Exosomal miR-218-5p/miR-363-3p from Endothelial Progenitor Cells Ameliorate Myocardial Infarction by Targeting the p53/JMY Signaling Pathway 